Agilon Health Inc [NYSE: AGL] stock went on a downward path that fall over -9.29% on Tuesday, amounting to a one-week price increase of more than 28.93%.
Over the last 12 months, AGL stock dropped by -82.33%. The one-year Agilon Health Inc stock forecast points to a potential upside of 33.87. The average equity rating for AGL stock is currently 2.94, trading closer to a bullish pattern in the stock market.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The market cap for the stock reached $844.64 million, with 406.39 million shares outstanding and 303.27 million shares in the current float. Compared to the average trading volume of 4.70M shares, AGL stock reached a trading volume of 4577482 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Guru’s Opinion on Agilon Health Inc [AGL]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for AGL shares is $3.10 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on AGL stock is a recommendation set at 2.94. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
JMP Securities have made an estimate for Agilon Health Inc shares, keeping their opinion on the stock as Mkt Perform, with their previous recommendation back on November 11, 2024. The new note on the price target was released on November 08, 2024, representing the official price target for Agilon Health Inc stock. Previously, the target price had yet another drop from $7 to $2.50, while Citigroup kept a Sell rating on AGL stock.
The Average True Range (ATR) for Agilon Health Inc is set at 0.25, with the Price to Sales ratio for AGL stock in the period of the last 12 months amounting to 0.15. The Price to Book ratio for the last quarter was 1.47, with the Price to Cash per share for the same quarter was set at 0.97.
AGL Stock Performance Analysis:
Agilon Health Inc [AGL] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 28.93. With this latest performance, AGL shares dropped by -24.07% in over the last four-week period, additionally sinking by -64.41% over the last 6 months – not to mention a drop of -82.33% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for AGL stock in for the last two-week period is set at 44.53, with the RSI for the last a single of trading hit 49.28, and the three-weeks RSI is set at 41.96 for Agilon Health Inc [AGL]. The present Moving Average for the last 50 days of trading for this stock 2.83, while it was recorded at 1.93 for the last single week of trading, and 4.94 for the last 200 days.
Insight into Agilon Health Inc Fundamentals:
Agilon Health Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.29 and a Current Ratio set at 1.29.
AGL Stock EPS
With the latest financial reports released by the company, Agilon Health Inc posted -0.41/share EPS, while the average EPS was predicted by analysts to be reported at -0.28/share. When compared, the two values demonstrate that the company fail the estimates by a Surprise Factor of -0.13. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for AGL.
Agilon Health Inc [AGL] Institutonal Ownership Details
There are presently around $105.04%, or 106.95%% of AGL stock, in the hands of institutional investors. The top three institutional holders of AGL stocks are: CLAYTON, DUBILIER & RICE, LLC with ownership of 100.0 million shares, which is approximately 24.3149%. FMR LLC, holding 56.93 million shares of the stock with an approximate value of $$372.3 million in AGL stocks shares; and FMR LLC, currently with $$368.94 million in AGL stock with ownership which is approximately 13.7168%.
